| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.1M | +6.8% | -20.4% |
| R&D Expense | $6.4M | +6.4% | -28.6% |
| SG&A Expense | $5.0M | -13.6% | +72.1% |
| Operating Income | -$8.3M | +6.7% | -3.8% |
| Pre-tax Income | -$17.5M | -135.2% | -131.9% |
| Income Tax | $0 | — | — |
| Net Income | -$17.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $30.8M | -5.0% | -15.9% |
| Short-term Investments | $0 | — | -100.0% |
| Accounts Receivable | $2.9M | -14.2% | +57.0% |
| Current Assets | $35.9M | -6.6% | -11.1% |
| Total Assets | $36.1M | -6.6% | -10.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$25.4M | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $25.9M | — | — |
| -131.9% |
| EPS (Basic) | -$0.25 | -108.3% | +13.8% |
| EPS (Diluted) | -$0.25 | -108.3% | +13.8% |
| $29.1M |
| +44.1% |
| +377.7% |
| Long-term Debt | $1.1M | +6.8% | — |
| Total Liabilities | $30.2M | +42.3% | +395.2% |
| Stockholders' Equity | $6.0M | -65.9% | -82.6% |